Overexpression of heme oxygenase-1 protects allogeneic thyroid grafts from rejection in naive mice

Surgery

Volumn 128, Issue 6, 2000, Pages 910-917

  Niimi, Masanori ^a,b,c,d   Takashina, Motoi ^a,b,c,d   Takami, Hiroshi ^a,b,c,d   Ikeda, Yoshifumi ^a,b,c,d   Shatari, Tomoo ^a,b,c,d   Hamano, Kimikazu ^a,b,c,d   Esato, Kensuke ^a,b,c,d   Matsumoto, Kenji ^a,b,c,d   Kameyama, Kaori ^a,b,c,d   Kodaira, Susumu ^a,b,c,d   Wood, Kathryn J ^a,b,c,d  

^a TEIKYO UNIVERSITY   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; COPPER DERIVATIVE; HEME OXYGENASE; MONOCLONAL ANTIBODY; PROTOPORPHYRIN; PROTOPORPHYRIN ZINC;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOCRINE DISEASE; GRAFT REJECTION; GRAFT SURVIVAL; KIDNEY CAPSULE; MOUSE; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID GLAND;

EID: 0033670025     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2000.109968     Document Type: Article

References (25)

1. A randomized trial comparing double-drug and triple drug therapy in primary cadaveric renal transplants
2. Risk of neoplasia in renal transplant patients
3. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance
4. Results of heart transplantation in mice
5. Assessment of primarily vascularized cardiac allografts in mice
6. The effect of anti-L3T4 monoclonal antibody treatment on first-set rejection of murine cardiac allografts
7. T cell subsets and the recognition of MHC class
8. Identification of a CD4 binding site on the *2 domain of HLA-DR molecules
9. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo
10. Prolonged survival of nonhuman primate renal allograft recipients treated with only anti-CD4 monoclonal antibody
11. CD4: A potential target molecule for immunosuppressive therapy and tolerance induction
12. Islet allograft survival after a single course of treatment of recipients with antibody to L3T4
13. Skin allograft rejection by L3T4+ and LYT-2+ T cell subsets
14. Manipulation of T-cell responses with monoclonal antibodies
15. + T cells
16. Accommodation of vascularized xenografts: Expression of 'protective gene' by donor endothelial cells in a host T(H2) cytokine environment
17. Expression of heme oxygenase-1 can determine cardiac xenograft survival
18. Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB
19. A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB- dependent gene activation in islets
20. The heme oxygenase-carbon monoxide system: A regulator of hepatobiliary function
21. Stress protein-induced immunosuppression: Inhibition of cellular immune effector functions following overexpression of haem oxygenase (HSP 32)
22. Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes
23. Gene transfer of immunomodulatory peptides correlates with heme oxygenase-1 induction and enhanced allograft survival
24. Oxidant stress leads to transcriptional activation of the human heme oxygenase gene in cultured skin fibroblasts
25. Induction of heme oxygenase: A general response to oxidant stress in cultured mammalian cells